EUVIMEDEUVIMED entdecken
Multizentrische Studie

Chronic subdural hematoma enhanced recovery pathway: targeting excellent outcomes

Srujana Venkata Vedicherla, Zakir Hassan Chew, Dave Thevandiran Kanavathy, Alethea Jern Ai Baskaran Nair, Christina Hui Ling Chia, Sarah Min Lim, Xiao Yuan Wu, David Chyi Yeu Low, Min Wei Chen, Jia Xu Lim

Neurosurgical Focus · 2025

DOI: 10.3171/2025.7.focus25531 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Neurosurgical Focus, 2025. Verfasst von Srujana Venkata Vedicherla und 9 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Neurosurgery, National Neuroscience Institute, Singapore. Hauptthemen laut MEDLINE: Hematoma, Subdural, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Chronic subdural hematoma (cSDH) is one of the most common neurosurgical pathologies. Despite the optimization of surgical approaches, outcomes such as recurrence and complication rates remain unacceptably high. Consolidated evidence-based pathways have demonstrated a clear impact on surgical outcomes. Herein, the authors aggregated literature evidence and institutional experience to design and implement an enhanced recovery pathway for cSDH. METHODS A multicenter cohort study was conducted over two periods: prior to (July 2021 to June 2022) and after (July 2022 to June 2023) pathway implementation. All adult patients with surgically evacuated cSDH or subacute subdural hematoma (SDH) were included in the study. Patients with SDHs that were managed conservatively, acute SDH treated with craniotomy or craniectomy, or subdural empyemas were excluded. Demographic details as well as preoperative clinical and radiological data were collected. Outcome measures included hospital length of stay (LOS), complication rate, discharge location, 30-day mortality, and 3-month recurrence. An excellent outcome was defined as discharge within a week of burr hole evacuation to a location similar to or better than premorbidly and no 3-month recurrence. RESULTS One hundred seventy prepathway and 169 postpathway patients were included in the final analysis and were comparable both demographically and clinically. After multivariable logistic regression analysis, the postpathway group had a shorter median LOS (9 vs 7 days, p = 0.003) and were more likely to be discharged to home or a rehabilitation facility (OR 2.77, 95% CI 1.45–5.56, p = 0.002). The 3-month recurrence rate reduced from 11.8% prepathway to 7.7% postpathway, although the difference between the two was not statistically significant (p = 0.13). Excellent outcomes were more likely postpathway, increasing from 34.7% to 49.7% (OR 1.92, 95% CI 1.19–3.13, p = 0.008). CONCLUSIONS The treatment of cSDH is ever evolving with newer adjuncts and treatment modalities described in the literature. However, with the simple standardization of care in patients with cSDH, a reduced LOS, an optimized patient discharge location, and an increase in the proportion of patients with excellent outcomes were noted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematoma, Subdural, ChronicHumansMaleFemaleAgedMiddle AgedTreatment OutcomeCohort StudiesAged, 80 and overLength of StayAdultRetrospective StudiesCraniotomy

Stichwörter der Autor:innen

chronic subdural hematomacomplicationsenhanced recovery pathwaylength of stayoutcomesrecurrence

Autor:innen und Institutionen

  • 1Department of Neurosurgery, National Neuroscience Institute, Singapore.
  • 2Department of Physiotherapy, Tan Tock Seng Hospital, Singapore; and.
  • Departments of3Physiotherapy and.
  • 4Occupational Therapy, Singapore General Hospital, Singapore.

Zitieren

APA

Vedicherla, S. V., Chew, Z. H., Kanavathy, D. T., Nair, A. J. A. B., Chia, C. H. L., Lim, S. M., Wu, X. Y., Low, D. C. Y., Chen, M. W., & Lim, J. X. (2025). Chronic subdural hematoma enhanced recovery pathway: targeting excellent outcomes. Neurosurgical Focus. https://doi.org/10.3171/2025.7.focus25531

Vancouver

Vedicherla SV, Chew ZH, Kanavathy DT, Nair AJAB, Chia CHL, Lim SM, et al. Chronic subdural hematoma enhanced recovery pathway: targeting excellent outcomes. Neurosurgical Focus. 2025. doi:10.3171/2025.7.focus25531

BibTeX
@article{Vedicherla2025,
  author = {Vedicherla, Srujana Venkata and Chew, Zakir Hassan and Kanavathy, Dave Thevandiran and Nair, Alethea Jern Ai Baskaran and Chia, Christina Hui Ling and Lim, Sarah Min and Wu, Xiao Yuan and Low, David Chyi Yeu and Chen, Min Wei and Lim, Jia Xu},
  title = {Chronic subdural hematoma enhanced recovery pathway: targeting excellent outcomes},
  journal = {Neurosurgical Focus},
  year = {2025},
  doi = {10.3171/2025.7.focus25531}
}
Kostenlos starten →